Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-arm Phase II Randomized Study, Comparing Adaptive Biological Imaging - Voxel Intensity - Based Radiotherapy (Adaptive Dose Escalation) Versus Standard Radiotherapy for Head and Neck Cancer.

NCT01341535 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT01341535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01341535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-arm Phase II Randomized Study, Comparing Adaptive Biological Imaging - Voxel Intensity - Based Radiotherapy (Adaptive Dose Escalation) Versus Standard Radiotherapy for Head and Neck Cancer.
Lead sponsor
University Hospital, Ghent
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2011
Completion date
July 15, 2021
Enrollment
100 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

primary non-operated squamous cell carcinoma of hypopharynx, primary non-operated squamous cell carcinoma of larynx, primary non-operated squamous cell carcinoma of oral cavity, primary non-operated squamous cell carcinoma of oropharynx